Summary
A study was carried out to determine whether beta-adrenergic hypersensitivity occurs in normal subjects following the abrupt withdrawal of the beta-adrenoceptor antagonist propranolol. Sixteen normal subjects took propranolol, orally, 120 mg twice daily for one week. Heart rate and blood pressure were measured supine and standing as well as during exercise. Heart rate was measured during and following the Valsalva manoeuvre. Measurements were made on the last day of the treatment period and on two occasions during the six days following withdrawal. Three subjects were removed from the analysis because of failure to take medication and one more was excluded because of protocol variation. In the remaining twelve, propranolol treatment reduced all parameters measured. Following abrupt withdrawal of the drug, there was no measurable increase in any of the parameters above baseline or placebo values within six days of the withdrawal. These findings, from normal subjects, do not support the phenomenon of beta-adrenergic hypersensitivity following propranolol withdrawal.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alderman EL, Coltart DJ, Wettach GE, Harrison DC (1974) Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med 81: 625–627
Baldwa VS, Ewing D (1977) Heart rate response to Valsalva manoeuvre. Reproducibility in normals, and relation to variation in resting heart rate in diabetics. Br Heart J 39: 641–644
Boudoulas H, Lewis RP, Kates RE, Dalamangas G (1977) Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. Ann Int Med 87: 433–436
Diaz RG, Somberg J, Freeman E, Levitt B (1974) Myocardial infarction after propranolol withdrawal. Am Heart J 88: 257–258
Eggleston PA, Rosenthal RR, Anderson SD, Anderton R, Bierman CW, Bleecker ER, Chai H, Cropp GJA, Johnson JD, Konig P, Morse J, Smith LJ, Summers RJ, Trautlien JJ (1979) Guidelines for methodology of exercise challenge testing of asthmatics. J Allergy Clin Immunol 64: 642–645
Frishman WH, Klein N, Strom J, Cohen MN, Shamoon H, Willens H, Klein P, Roth S, Iorio L, LeJemtel T, Pollack S, Sonnenblick EH (1982) Comparative effects of abrupt withdrawal of propranolol and verapamil in angina patients. Am J Cardiol 50: 1191–1195
Grizzle JE (1965) The two-period change-over design and its use in clinical trials. Biometrics 21: 467–480
Hills M, Armitage P (1979) The two-period cross-over clinical trial. Br J Clin Pharmacol 8: 7–20
Kiyingi KS, Shaw J (1984) Propranolol withdrawal hypersensitivity: not enough evidence. Clin Exp Pharmacol Physiol (in press)
Miller RR, Oslon HG, Amsterdam EA, Mason DT (1975) Propranolol withdrawal rebound phenomenon. N Eng J Med 293: 416–418
Mizgalla HF, Counsell J (1976) Acute coronary syndromes following abrupt cessation of oral propranolol therapy. Can Med Assoc J 114: 1123–1126
Myers JH, Horwitz LD (1978) Hemodynamic and metabolic response after abrupt withdrawal of long-term propranolol. Circulation 58: 196–201
Myers MG, Wisenberg G (1977) Sudden withdrawal of propranolol in patients with angina pectoris. Chest 71: 24–26
Myers MG, Freeman MR, Juma ZA, Wisenberg G (1979) Propranolol withdrawal in angina pectoris: a prospective study. Am Heart J 97: 298–302
Nattel S, Rangno RE, Van Loon G (1979) Mechanism of propranolol withdrawal phenomena. Circulation 59: 1158–1164
Prichard BNC, Walden RJ (1982) The syndrome associated with the withdrawal of β-adrenergic receptor blocking drugs. Br J Clin Pharmacol 13: 337S–343S
Prichard BNC, Tomlinson B, Walden RJ, Bhattacharjee P (1983) The β-adrenergic blockade withdrawal phenomenon. J Cardiovasc Pharmacol 5: S56–S62
Raabe DS, Meengs WL, Crary JL, Sorkin RP, Gregory JM, Walton JA (1975) Risk of suddenly discontinuing propranolol therapy before coronary arteriography. Circulation 52 [Suppl II]: 12
Rangno RE, Langlois S (1982) Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol. J Clin Pharmacol 13: 345S–351S
Ross PJ, Lewis MJ, Sheridan DJ, Henderson AH (1981) Adrenergic hypersensitivity after beta-blocker withdrawal. Br Heart J 45: 637–642
Shiroff RA, Mathis J, Zelis R, Schneck DW, Babb JD, Leaman DM, Hayes AH Jr (1978) Propranolol rebound — A retrospective study. Am J Cardiol 41: 778–780
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kiyingi, K.S., Shaw, J. The phenomenon of β-adrenergic hypersensitivity following propranolol withdrawal studied in normal subjects. Eur J Clin Pharmacol 27, 423–428 (1984). https://doi.org/10.1007/BF00549589
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00549589